Our vision
To be global leaders discovering what causes diseases, how to slow, cure and prevent. We host scientists who see beyond prevailing dogma, who have novel but unproven hypotheses and who have an insatiable appetite to explore the unexplored.
Our research
We are seamless, studying genes-to-populations, supporting student-scientists-to-professors, integrating patient consumers-with-doctors and hosting volunteers-to-technology specialists. A shared-responsibility model to improve the lives of Australians living with disease, sooner.
Our facilities
We host state-of-the-art technology platforms in contemporary certified PC2 facilities, home to ~300 scientists.
Support CHIRI
Whether you are an individual, foundation, corporate or service provider, your donation – large or small – will further support our four key research areas as we strive to be bold and innovative and improve the quality of life for countless Australians.
Our focus areas
Our research encompasses four focus areas, or areas of strength, including vascular and metabolic disorders, inflammation, infectious disease and wounds, neurodegenerative disorders and cancer.
Vascular and Metabolic Disorders
We are identifying new treatments for blood vessel disorders and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
Inflammation, Infectious Disease and Wounds
We are developing ways to stop the decline in immune system function with ageing, using the immune system to treat arthritis and adult cancers.
Neurodegenerative and Pain
We are exploring new approaches for preventing and treating Alzheimer’s disease, where we’re hoping to slow cognitive decline significantly.
Cancer
We’re researching interventions for age-associated cancers, focusing on how the immune system influences cancer risk and disease progression.
CHIRI in the news
CHIRI Director Professor John Mamo named as Finalist for Scientist of the Year
Ground-breaking Alzheimer’s researcher John Curtin Distinguished Professor John Mamo, CHIRI Director has been named as a finalist for Scientist of…
CHIRI researchers map genetic signature of precursor to liver cancer
CHIRI researchers have identified the genetic signature of pre-malignant liver cells, offering potentially significant implications for the almost 3,000 Australians…
New tests seek to predict liver cancer relapse and improve survival rates
CHIRI researchers will develop a suite of tissue and blood-based diagnostic tests that can predict whether liver cancer will return.
New projects to fight lung infections and boost Indigenous physical activity
Curtin University researchers will develop and for the first time test in humans new treatments for lung infections that are…
Subscribe for updates
Stay up-to-date with our latest news on research, community and events.